ANDRES ORDONEZ: Open Payments
NPI 1194835033 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,893 in 114 payments from 17 companies in 2025. Trend: 2023 $2,579 · 2024 $2,664 · 2025 $2,893
Food & beverage: $2,893
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $669 |
| Aimmune Therapeutics, Inc. | 55 | $532 |
| Lilly USA, LLC | 5 | $368 |
| ABBVIE INC. | 12 | $285 |
| Amgen Inc. | 8 | $191 |
| Madrigal Pharmaceuticals | 1 | $135 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $133 |
| GlaxoSmithKline, LLC. | 1 | $110 |
| Phathom Pharmaceuticals, Inc. | 3 | $95 |
| Hollister Incorporated | 1 | $79 |
Products named: ZENPEP, Ozempic, Wegovy, REZDIFFRA, ISTURISA, LINZESS, MOUNJARO, CREON.
Industry payments across CA — which companies pay providers there.
